We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Sphere Medical

Commercialisation now begins

Update | 15 December 2016

Karolinska Development

Another quarter of delivery

Update | 23 November 2016

Karolinska Development

The corner has been turned

Initiation | 09 November 2016

Sphere Medical

CE Mark opens the door to commercialisation

Update | 30 September 2016

MaxCyte

Gearing up the growth

Update | 27 September 2016

Sphere Medical

On the cusp of commercialisation

Update | 22 September 2016

Sphere Medical

First Belgian order for Proxima confirmed

Update | 30 August 2016

Sphere Medical

CE Mark expected shortly, launch preparations on track

Update | 21 July 2016

MaxCyte

Right here, right now: catching the CAR-T wave

Initiation | 12 July 2016

Sphere Medical

Worthy of further evaluation

Initiation | 26 February 2016
1 2 3 4 5 6 7 8 9 10 11
110 results found.